341 related articles for article (PubMed ID: 36979630)
1. Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?
Robotti M; Scebba F; Angeloni D
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979630
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine.
Záveský L; Slanař O
Methods Mol Biol; 2023; 2630():135-143. PubMed ID: 36689181
[TBL] [Abstract][Full Text] [Related]
3. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
Mandilaras V; Vernon M; Meryet-Figuière M; Karakasis K; Lambert B; Poulain L; Oza A; Denoyelle C; Lheureux S
Expert Opin Biol Ther; 2017 Aug; 17(8):927-943. PubMed ID: 28641048
[TBL] [Abstract][Full Text] [Related]
4. The Salivary miRNome: A Promising Biomarker of Disease.
Tomei S; Manjunath HS; Murugesan S; Al Khodor S
Microrna; 2021; 10(1):29-38. PubMed ID: 33845754
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
6. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
7. Use of Salivary MicroRNAs for Diagnosis of Solid Cancers.
Kubíčková A; Slabý O
Klin Onkol; 2018; 31(4):249-259. PubMed ID: 30541306
[TBL] [Abstract][Full Text] [Related]
8. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
Singh A; Gupta S; Sachan M
Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
[TBL] [Abstract][Full Text] [Related]
11. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
Novak J; Souček M
Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
[TBL] [Abstract][Full Text] [Related]
12. The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer.
Qin X; Xu H; Gong W; Deng W
Front Oncol; 2014; 4():357. PubMed ID: 25601903
[TBL] [Abstract][Full Text] [Related]
13. Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis.
Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Hasanzadeh M; Parizadeh SMR; Hassanian SM; Rezaei-Kalat A; Aghabozorgi AS; Rahimi-Kakhki R; Zargaran B; Ferns GA; Avan A
Curr Drug Targets; 2019; 20(14):1447-1460. PubMed ID: 31284859
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
15. Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer.
Scebba F; Salvadori S; Cateni S; Mantellini P; Carozzi F; Bisanzi S; Sani C; Robotti M; Barravecchia I; Martella F; Colla V; Angeloni D
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958700
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as novel non-invasive biomarkers of paediatric celiac disease and adherence to gluten-free diet.
Felli C; Baldassarre A; Uva P; Alisi A; Cangelosi D; Ancinelli M; Caruso M; Paolini A; Montano A; Silano M; Vincentini O; Catassi C; Lionetti E; Gatti S; Ferretti F; Masotti A
EBioMedicine; 2022 Feb; 76():103851. PubMed ID: 35151110
[TBL] [Abstract][Full Text] [Related]
17. Urinary extracellular vesicles miRNA-A new era of prostate cancer biomarkers.
Jain G; Das P; Ranjan P; Neha ; Valderrama F; Cieza-Borrella C
Front Genet; 2023; 14():1065757. PubMed ID: 36741322
[TBL] [Abstract][Full Text] [Related]
18. Circulating MicroRNAs as Cancer Biomarkers in Liquid Biopsies.
Suárez B; Solé C; Márquez M; Nanetti F; Lawrie CH
Adv Exp Med Biol; 2022; 1385():23-73. PubMed ID: 36352210
[TBL] [Abstract][Full Text] [Related]
19. Distribution of microRNA biomarker candidates in solid tissues and body fluids.
Fehlmann T; Ludwig N; Backes C; Meese E; Keller A
RNA Biol; 2016 Nov; 13(11):1084-1088. PubMed ID: 27687236
[TBL] [Abstract][Full Text] [Related]
20. Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy.
Raz V; Kroon RHMJM; Mei H; Riaz M; Buermans H; Lassche S; Horlings C; Swart B; Kalf J; Harish P; Vissing J; Kielbasa S; van Engelen BGM
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
